Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a small software update to the page’s framework. This change does not modify the study content or user-facing data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3 to reflect a newer, minor update to the page's documentation/version history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.0 to v3.5.3, indicating a website software/version change rather than a change to the clinical trial information.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check99 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check121 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor site maintenance or version update; there are no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.